Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 18.
doi: 10.1055/a-2703-4537. Online ahead of print.

Cryptogenic Organizing Pneumonia

Affiliations

Cryptogenic Organizing Pneumonia

Michael Z Root et al. Semin Respir Crit Care Med. .

Abstract

Cryptogenic organizing pneumonia (COP), formerly called bronchiolitis obliterans organizing pneumonia (BOOP), was first described in the 1980s and is classified as a rare idiopathic interstitial pneumonia (IIP). COP classically presents in a subacute fashion following a flu-like illness with fever, non-productive cough, and fatigue. Imaging often reveals diffuse, bilateral, peribronchovascular and peripheral consolidative and ground glass opacities although various imaging subtypes also exist. Physical exam may be normal or reveal inspiratory crackles. Hypoxemia, when present, is commonly identified with exertion but can also occur at rest. Diagnostic evaluation relies on excluding secondary causes of organizing pneumonia and includes a thorough history including medications, exposures, and signs or symptoms of underlying rheumatologic disease. Invasive diagnostic testing including tissue sampling allows for histopathologic confirmation of COP while excluding secondary causes including infection and malignancy. While video-assisted thorascopic surgery (VATS) lung biopsy is often the preferred method of obtaining sufficient tissue, less invasive means may be employed based on patient-specific factors. A defining feature of COP is steroid-responsiveness, and most experts recommend prolonged corticosteroid courses (6-12 months). Response to corticosteroids and prognosis is typically excellent. Relapse rates range from 25-50% and occur most often during steroid taper or complete withdrawal necessitating additional therapy. Steroid-sparing immunosuppression may be used in select circumstances. Further study is needed to define optimal corticosteroid dose and duration.

PubMed Disclaimer

Conflict of interest statement

Michael Root None Joyce Lee I have received grants from the NIH and Boehringer Ingelheim, outside the submitted work. I have received an unrestricted research gift from Pliant, outside the submitted work. I have received consulting fees from Blade, Boehringer Ingelheim, Astra Zeneca, Elima, Gatehouse Bio, Mannkind, Syndax, Mediar Therapeutics, Abbvie, BMS, Avalyn and Eleven P15, outside the submitted work. I am/have been a DSMB member for United Therapeutics and Pulmovant, outside the submitted work I am an advisor for the Pulmonary Fibrosis Foundation, outside the submitted work. I am a section editor for UpToDate and Merck, outside the submitted work.

LinkOut - more resources